PBYI Puma Biotechnology Inc - Common Stock

NASDAQ · Biotechnology · SEC EDGAR पर देखें ↗
$9.41
मूल्य · अग 19, 2026
मौलिकता इस प्रकार है अग 6, 2026

Puma Biotechnology Inc - Common Stock के बारे में विकिपीडिया से कंपनी का अवलोकन

Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.

और पढ़ें

Puma Biotechnology is a publicly traded biopharmaceutical company (NASDAQ: PBYI) headquartered in Los Angeles, CA.

Creation

Puma was founded in September 2010 by Alan Auerbach to identify and in-license compounds that were already in clinical development. This was the same business plan Auerbach had followed at Cougar Biotechnology, which he founded in 2003, and through which he in-licensed abiraterone acetate from BTG plc. Cougar further developed abiraterone before the company was sold to Johnson & Johnson in 2009. Auerbach brought many Cougar employees with him after founding Puma in 2010.

Funding for development

In August 2011 Puma licensed two drug candidates from Pfizer: neratinib (PB272) and an analog (PB357) to serve as a backup candidate.

As part of an approximately $60 million financing round in October 2011, Puma entered into a reverse merger with the shell company Innovative Acquisitions Corp., formed in 2007. In April 2012 the company's stock began trading over the counter. In October 2012 the company raised around $138 million and its shares were listed on the New York Stock Exchange.

In 2016 Puma discovered that Robert Gadimian, senior director of regulatory affairs, had twice bought and sold stock based on his knowledge of unpublished clinical trial results; Puma quickly fired him after conducting an internal investigation and reported the insider trading to the SEC.

Approval and licensing of neratinib

In March 2016 Puma held a pre-NDA meeting with the FDA in which the FDA raised concerns about the design and conduct of clinical trials that Puma had run and recommended that Puma not file the NDA with that data.

Puma did file the NDA, and in May 2017 an FDA review panel recommended that the FDA approve neratinib but raised concerns that the intended use was too broad and should be limited to people with specific mutations. The FDA's briefing document to the panel had raised concerns about the marginal benefit of the drug and the side effects. In July 2017 the FDA approved neratinib for use in preventing the return of breast cancer after treatment that included trastuzumab and without any need for genetic testing, and with warnings about the risk of severe diarrhea. U.S. sales of neratinib totaled $200.5 million in 2018.

In January 2018 an EMA committee gave a negative review to neratinib. In June 2018 this same EMA committee recommended the approval of neratinib, which received European Commission (EC) approval in September 2018.

In 2019 Puma licensed commercialization rights in Europe and part of Africa to Pierre Fabre for an upfront payment of $60 million and milestone payments that could reach $345 million. Previously, Puma licensed rights in Greater China to CANbrdige Life Sciences, rights in Israel to Medison Pharma, rights in Canada to Knight Therapeutics, rights in South East Asian to Specialised Therapeutics and rights in Latin America to Pint Pharma.

== References ==

स्रोत: विकिपीडिया (अंग्रेज़ी), CC BY-SA 4.0 · विकिपीडिया पर देखें ↗

Wikidata ↗

PBYI स्टॉक स्नैपशॉट मूल्य, बाजार पूंजीकरण, P/E, EPS, ROE, ऋण/इक्विटी, 52-सप्ताह की सीमा

मूल्य
$9.41
मार्केट कैप
$479M
P/E (TTM)
15.6
EPS (TTM)
$0.61
राजस्व (TTM)
$228M
लाभांश प्रतिफल
ROE
26.5%
D/E ऋण/इक्विटी
0.2
52W रेंज
$4 – $10

PBYI स्टॉक मूल्य चार्ट तकनीकी संकेतकों के साथ दैनिक OHLCV — पैन, ज़ूम और अपना दृश्य कस्टमाइज़ करें

10-वर्षीय प्रदर्शन राजस्व, शुद्ध आय, मार्जिन और ईपीएस रुझान

राजस्व और शुद्ध आय $228M
9-point trend, +724.9%
2017-12-31 2025-12-31
EPS $0.61
6-point trend, +140.1%
2020-12-31 2025-12-31
फ्री कैश फ्लो $42M
8-point trend, +128.6%
2016-12-31 2025-12-31
मार्जिन 13.6%

मूल्यांकन P/E, P/S, P/B, EV/EBITDA अनुपात — क्या स्टॉक महंगा है या सस्ता?

मेट्रिक
5Y रुझान
PBYI
सहकर्मी माध्यिका
P/E (TTM)
5-point trend, +244.5%
15.6
17.4
P/S (TTM)
5-point trend, +172.8%
2.1
52.3
P/B
5-point trend, +104.6%
3.7
4.8
EV / EBITDA
5-point trend, -94.3%
10.8
Price / FCF (मूल्य / FCF)
5-point trend, +21.8%
11.5

लाभप्रदता सकल, परिचालन और शुद्ध मार्जिन; ROE, ROA, ROIC

मेट्रिक
5Y रुझान
PBYI
सहकर्मी माध्यिका
Operating Margin (परिचालन मार्जिन)
5-point trend, +3102.0%
16.3%
Net Profit Margin (शुद्ध लाभ मार्जिन)
5-point trend, +218.3%
13.6%
-670.1%
ROA
5-point trend, +217.1%
14.5%
-41.1%
ROE
5-point trend, -93.9%
26.5%
-52.6%
ROIC
5-point trend, +1437.7%
21.2%

वित्तीय स्वास्थ्य ऋण, तरलता, शोधन क्षमता — बैलेंस शीट की मजबूती

मेट्रिक
5Y रुझान
PBYI
सहकर्मी माध्यिका
Debt / Equity (ऋण / इक्विटी)
5-point trend, +100.4%
0.2
Current Ratio (वर्तमान अनुपात)
5-point trend, +56.7%
2.0
7.7
Quick Ratio (त्वरित अनुपात)
5-point trend, +77.9%
1.9

विकास राजस्व, EPS और शुद्ध आय वृद्धि: YoY, 3Y CAGR, 5Y CAGR

मेट्रिक
5Y रुझान
PBYI
सहकर्मी माध्यिका
Revenue YoY (राजस्व YoY)
5-point trend, -9.8%
-0.91%
Revenue CAGR 3Y (राजस्व CAGR 3Y)
5-point trend, -9.8%
0.05%
Revenue CAGR 5Y (राजस्व CAGR 5Y)
5-point trend, -9.8%
0.29%
EPS YoY
5-point trend, +184.7%
-1.6%
Net Income YoY (शुद्ध आय YoY)
5-point trend, +206.8%
2.8%

प्रति शेयर मेट्रिक्स EPS, प्रति शेयर बुक वैल्यू, प्रति शेयर नकदी प्रवाह, प्रति शेयर लाभांश

मेट्रिक
5Y रुझान
PBYI
सहकर्मी माध्यिका
EPS (Diluted) (EPS (तनुभूत))
5-point trend, +184.7%
$0.61

पूंजी दक्षता एसेट टर्नओवर, इन्वेंटरी टर्नओवर, प्राप्य टर्नओवर

मेट्रिक
5Y रुझान
PBYI
सहकर्मी माध्यिका

PBYI विश्लेषक सर्वसम्मति तेजी और मंदी के विश्लेषक राय, 12-महीने का मूल्य लक्ष्य, अपसाइड

बेचें 6 विश्लेषक
  • मजबूत खरीद 0 0.0%
  • खरीदें 0 0.0%
  • होल्ड 3 50.0%
  • बेचें 1 16.7%
  • मजबूत बिक्री 2 33.3%

12-महीने का मूल्य लक्ष्य

1 विश्लेषक · 2026-08-18
मध्यिका लक्ष्य $6.00 -36.2%
माध्य लक्ष्य $6.00 -36.2%

Earnings History EPS वास्तविक बनाम अनुमान, आश्चर्य %, बीट दर, अगली आय तिथि

औसत आश्चर्य
0.07%
Period EPS Actual EPS अनुमान आश्चर्य
30 जून 2026 $0.16 $0.04 0.12%
31 मार्च 2026 $-0.07 $-0.13 0.06%
31 दिसमबर 2025 $0.26 $0.23 0.03%
30 सितमबर 2025 $0.17 $0.05 0.12%
30 जून 2025 $0.12 $0.10 0.02%
31 मार्च 2025 $0.06 $-0.02 0.08%

सहकर्मी तुलना (GICS उप-उद्योग) प्रमुख मेट्रिक्स बनाम सेक्टर के साथी

टिकर मार्केट कैप P/E राजस्व YoY शुद्ध मार्जिन ROE सकल मार्जिन
PBYI $300M 9.8 -0.91% 13.6% 26.5%
CABA $220M -1.0 -115.5%
QTTB $43M 1.4 55.5% 200.3%
OCGN $422M -5.6 8.8% -1537.4% 1488.8%
LRMR $317M -2.2 -167.4%
RZLT $388M -4.6 -56.9%
BNTC $307M -11.1 -43.8%
EDIT $201M -1.1 25.4% -395.0% -688.8%
CMPX $958M -45.9%
PROK 1075.0% -7725.2% 6.9%

पूर्ण मौलिक सभी मेट्रिक्स प्रति वर्ष — आय विवरण, बैलेंस शीट, नकदी प्रवाह

आय विवरण 17
PBYI के लिए वार्षिक आय विवरण डेटा
मेट्रिक रुझान 202520242023202220212020201920182017
Revenue 9-point trend, +724.9% $228M $230M $236M $228M $253M $225M $272M $251M $28M
Cost of Revenue 9-point trend, +943.7% $58M $64M $63M $55M $64M $39M $37M $35M $6M
R&D Expense 5-point trend, -65.4% · · · · $72M $98M $133M $165M $208M
SG&A Expense 9-point trend, -33.6% $71M $80M $90M $90M $116M $118M $142M $146M $107M
Operating Expenses 9-point trend, -40.3% $191M $200M $203M $204M $252M $256M $311M $346M $320M
Operating Income 9-point trend, +112.8% $37M $31M $33M $24M $1M $-30M $-39M $-95M $-292M
Interest Expense 7-point trend, +1751.4% · · $13M $12M $13M $14M $15M $11M $720.0K
Interest Income 9-point trend, +224.7% $4M $5M $3M $813.0K $160.0K $489.0K $3M $2M $1M
Other Non-op 9-point trend, +1116.8% $1M $862.0K $759.0K $-28.0K $292.0K $367.0K $128.0K $-714.0K $-101.0K
Pretax Income 8-point trend, +131.5% $36M $24M $23M $457.0K $-29M $-60M $-76M $-114M ·
Income Tax 9-point trend, +4671000.00 $5M $-6M $1M $455.0K $324.0K $207.0K $53.0K $17.0K $0
Net Income 9-point trend, +110.7% $31M $30M $22M $2.0K $-29M $-60M $-76M $-114M $-292M
EPS (Basic) 7-point trend, +100.0% $0.62 $0.62 $0.46 $0.00 $-0.72 $-1.52 $-75595.00 · ·
EPS (Diluted) 6-point trend, +140.1% $0.61 $0.62 $0.45 $0.00 $-0.72 $-1.52 · · ·
Shares (Basic) 6-point trend, +26.4% 50,011,485 48,648,701 47,134,331 44,674,501 40,638,852 39,576,107 · · ·
Shares (Diluted) 6-point trend, +28.0% 50,653,283 49,100,433 47,550,852 44,929,998 40,638,852 39,576,107 · · ·
EBITDA 9-point trend, +112.8% $37M $31M $33M $24M $1M $-30M $-39M $-95M $-292M
बैलेंस शीट 26
PBYI के लिए वार्षिक बैलेंस शीट डेटा
मेट्रिक रुझान 202520242023202220212020201920182017
Cash & Equivalents 9-point trend, -63.7% $30M $69M $85M $76M $63M $85M $60M $108M $82M
Short-term Investments 8-point trend, +19.1% $68M $32M $11M $5M $19M $8M $52M $57M ·
Receivables 9-point trend, +454.9% $54M $32M $48M $40M $33M $26M $29M $21M $10M
Inventory 9-point trend, +171.8% $6M $9M $7M $5M $7M $3M $3M $3M $2M
Prepaid Expense 9-point trend, -72.0% $4M $6M $4M $6M $9M $11M $13M $12M $13M
Other Current Assets 8-point trend, -85.7% $256.0K $91.0K $912.0K $2M $447.0K $4M $323.0K $2M ·
Current Assets 9-point trend, +52.9% $163M $148M $156M $134M $140M $146M $166M $203M $106M
PP&E (Net) 9-point trend, -95.8% $187.0K $515.0K $855.0K $1M $2M $2M $3M $4M $4M
PP&E (Gross) 9-point trend, -43.9% $5M $8M $9M $9M $9M $9M $9M $9M $9M
Accum. Depreciation 9-point trend, +13.2% $5M $8M $8M $7M $7M $6M $6M $5M $4M
Intangibles 9-point trend, -14.4% $41M $51M $61M $71M $66M $74M $40M $44M $48M
Total Assets 9-point trend, +30.7% $216M $213M $231M $222M $227M $244M $235M $259M $166M
Accounts Payable 9-point trend, -81.7% $5M $6M $7M $6M $11M $12M $19M $21M $28M
Accrued Liabilities 9-point trend, +63.2% $50M $37M $53M $53M $93M $61M $69M $46M $31M
Current Liabilities 9-point trend, +39.3% $81M $96M $99M $77M $110M $114M $91M $67M $58M
Capital Leases 7-point trend, -79.2% $5M $1M $7M $12M $16M $20M $23M · ·
Other Non-current Liabilities 3-point trend, -100.0% $0 $121.0K $121.0K · · · · · ·
Total Liabilities 9-point trend, -23.4% $86M $121M $177M $200M $229M $250M $217M $225M $112M
Long-term Debt 9-point trend, -53.2% $23M $68M $102M $102M $102M $84M $95M $152M $48M
Total Debt 6-point trend, -77.1% $23M $67M $100M $98M $97M $98M · · ·
Common Stock 9-point trend, +25.0% $5.0K $5.0K $5.0K $5.0K $4.0K $4.0K $4.0K $4.0K $4.0K
Retained Earnings 9-point trend, -17.9% $-1.28B $-1.31B $-1.35B $-1.37B $-1.37B $-1.34B $-1.28B $-1.20B $-1.09B
AOCI 8-point trend, +400.0% $36.0K $6.0K $-4.0K $0 $-2.0K $0 $62.0K $-12.0K ·
Stockholders' Equity 9-point trend, +144.5% $130M $92M $53M $22M $-2M $-6M $17M $34M $53M
Liabilities + Equity 9-point trend, +30.7% $216M $213M $231M $222M $227M $244M $235M $259M $166M
Shares Outstanding 9-point trend, +34.1% 50,408,023 49,105,834 47,646,787 46,345,660 41,175,507 40,086,387 39,203,304 38,325,037 37,594,851
नकदी प्रवाह 14
PBYI के लिए वार्षिक नकदी प्रवाह डेटा
मेट्रिक रुझान 202520242023202220212020201920182017
D&A 9-point trend, +289.1% $11M $12M $12M $10M $11M $10M $8M $7M $3M
Stock-based Comp 9-point trend, -93.6% $7M $8M $10M $12M $33M $37M $57M $87M $109M
Deferred Tax 4-point trend, +3245000.00 $3M $-7M $0 $0 · · · · ·
Amort. of Intangibles 9-point trend, +506.2% $10M $10M $8M $8M $8M $6M $4M $4M $2M
Operating Cash Flow 9-point trend, +124.2% $42M $39M $27M $-16M $21M $773.0K $22M $-24M $-172M
CapEx 9-point trend, -83.5% $71.0K $56.0K $140.0K $0 $0 $46.0K $306.0K $439.0K $431.0K
Investing Cash Flow 9-point trend, -134.4% $-36M $-20M $-19M $7M $-11M $33M $5M $-58M $-15M
Debt Issued 3-point trend, -50.0% · · · · · · $25M $105M $50M
Net Debt Issued 3-point trend, -50.0% · · · · · · $25M $105M $50M
Financing Cash Flow 9-point trend, -160.2% $-45M $-34M $0 $12M $-32M $-10M $-67M $108M $75M
Net Change in Cash 9-point trend, +64.9% $-40M $-15M $8M $4M $-22M $24M $-40M $27M $-113M
Taxes Paid $1M · · · · · · · ·
Free Cash Flow 7-point trend, +124.1% $42M $39M $27M $-16M $21M · · $-25M $-173M
Levered FCF 3-point trend, +84.1% · · $14M $-16M $8M · · · ·
लाभप्रदता 7
PBYI के लिए वार्षिक लाभप्रदता डेटा
मेट्रिक रुझान 202520242023202220212020201920182017
Operating Margin 9-point trend, +101.5% 16.3% 13.4% 13.9% 10.4% 0.51% -13.5% -14.4% -37.7% -1056.1%
Net Margin 9-point trend, +101.3% 13.6% 13.1% 9.2% 0.00% -11.5% -26.7% -27.8% -45.2% -1054.6%
Pretax Margin 6-point trend, +159.0% 15.7% 10.5% 9.6% 0.20% -11.4% -26.6% · · ·
EBITDA Margin 9-point trend, +101.5% 16.3% 13.4% 13.9% 10.4% 0.51% -13.5% -14.4% -37.7% -1056.1%
ROA 9-point trend, +110.4% 14.5% 13.6% 9.5% 0.00% -12.4% -25.0% -30.6% -53.5% -139.6%
ROE 9-point trend, +111.9% 26.5% 37.1% 46.8% 0.01% 435.8% 1873.7% -436.4% -283.2% -221.9%
ROIC 6-point trend, +164.2% 21.2% 24.4% 20.3% 0.09% 1.4% -33.0% · · ·
तरलता और शोधन क्षमता 5
PBYI के लिए वार्षिक तरलता और शोधन क्षमता डेटा
मेट्रिक रुझान 202520242023202220212020201920182017
Current Ratio 9-point trend, +9.8% 2.0 1.5 1.6 1.7 1.3 1.3 1.8 3.0 1.8
Quick Ratio 9-point trend, +18.8% 1.9 1.4 1.4 1.6 1.0 1.0 1.5 2.8 1.6
Debt / Equity 6-point trend, +101.0% 0.2 0.7 1.9 4.5 -39.7 -16.5 · · ·
LT Debt / Equity 6-point trend, +100.0% 0.0 0.2 1.2 4.5 -39.7 -14.1 · · ·
Interest Coverage 7-point trend, +100.6% · · 2.4 2.0 0.1 -2.2 -2.6 -8.6 -406.1
दक्षता 3
PBYI के लिए वार्षिक दक्षता डेटा
मेट्रिक रुझान 202520242023202220212020201920182017
Asset Turnover 9-point trend, +702.9% 1.1 1.0 1.0 1.0 1.1 0.9 1.1 1.2 0.1
Inventory Turnover 7-point trend, +48.7% 8.2 8.2 10.8 9.5 12.1 · · 14.9 5.5
Receivables Turnover 9-point trend, -6.9% 5.3 5.8 5.3 6.3 8.7 8.3 11.0 16.5 5.7
प्रति शेयर 5
PBYI के लिए वार्षिक प्रति शेयर डेटा
मेट्रिक रुझान 202520242023202220212020201920182017
Book Value / Share 9-point trend, +82.4% $2.59 $1.88 $1.12 $0.52 $-0.06 $-0.15 $0.45 $0.90 $1.42
Revenue / Share 4-point trend, -11.2% $4.51 $4.69 $4.96 $5.08 · · · · ·
Cash Flow / Share 4-point trend, +334.3% $0.83 $0.79 $0.57 $-0.35 · · · · ·
Cash / Share 9-point trend, -72.9% $0.59 $1.41 $1.78 $1.85 $1.57 $2.13 $1.53 $2.83 $2.17
EPS (TTM) 6-point trend, +140.1% $0.61 $0.62 $0.45 $0.00 $-0.72 $-1.52 · · ·
विकास दरें 6
PBYI के लिए वार्षिक विकास दरें डेटा
मेट्रिक रुझान 202520242023202220212020201920182017
Revenue YoY 5-point trend, -107.3% -0.91% -2.2% 3.3% -9.9% 12.5% · · · ·
Revenue CAGR 3Y 3-point trend, -96.8% 0.05% -3.1% 1.5% · · · · · ·
Revenue CAGR 5Y 0.29% · · · · · · · ·
EPS YoY 2-point trend, -104.3% -1.6% 37.8% · · · · · · ·
Net Income YoY 3-point trend, -100.0% 2.8% 40.2% 1079450.0% · · · · · ·
Net Income CAGR 3Y 2396.3% · · · · · · · ·
मूल्यांकन (TTM) 14
PBYI के लिए वार्षिक मूल्यांकन (TTM) डेटा
मेट्रिक रुझान 202520242023202220212020201920182017
Revenue TTM 9-point trend, +724.9% $228M $230M $236M $228M $253M $225M $272M $251M $28M
Net Income TTM 9-point trend, +110.7% $31M $30M $22M $2.0K $-29M $-60M $-76M $-114M $-292M
Market Cap 9-point trend, -91.9% $300M $150M $206M $174M $122M $411M $343M $780M $3.72B
Enterprise Value 6-point trend, -46.0% $225M $116M $210M $191M $137M $416M · · ·
P/E 5-point trend, +244.5% 9.8 4.9 9.6 · -4.2 -6.8 · · ·
P/S 9-point trend, -99.0% 1.3 0.6 0.9 0.8 0.5 1.8 1.3 3.1 134.2
P/B 9-point trend, -96.7% 2.3 1.6 3.9 8.1 -49.8 -69.1 19.6 22.7 69.7
P / Tangible Book 2-point trend, -7.7% 3.4 3.7 · · · · · · ·
P / Cash Flow 9-point trend, +133.3% 7.2 3.8 7.6 -11.0 5.9 532.1 15.3 -32.4 -21.5
P / FCF 7-point trend, +133.4% 7.2 3.9 7.7 -11.0 5.9 · · -31.8 -21.5
EV / EBITDA 6-point trend, +144.0% 6.0 3.7 6.4 8.1 106.1 -13.7 · · ·
EV / FCF 5-point trend, -18.7% 5.4 3.0 7.8 -12.1 6.6 · · · ·
EV / Revenue 6-point trend, -46.7% 1.0 0.5 0.9 0.8 0.5 1.8 · · ·
Earnings Yield 6-point trend, +169.2% 10.2% 20.3% 10.4% 0.00% -23.7% -14.8% · · ·

वित्तीय विवरण आय विवरण, बैलेंस शीट, नकदी प्रवाह — वार्षिक, पिछले 5 वर्ष

आय विवरण
2025-12-312024-12-312023-12-312022-12-312021-12-31
राजस्व $228M$230M$236M$228M$253M
परिचालन मार्जिन % 16.3%13.4%13.9%10.4%0.51%
शुद्ध आय $31M$30M$22M$2.0K$-29M
तनुकरणित EPS $0.61$0.62$0.45$0.00$-0.72
बैलेंस शीट
2025-12-312024-12-312023-12-312022-12-312021-12-31
ऋण / इक्विटी 0.20.71.94.5-39.7
वर्तमान अनुपात 2.01.51.61.71.3
त्वरित अनुपात 1.91.41.41.61.0
नकदी प्रवाह
2025-12-312024-12-312023-12-312022-12-312021-12-31
फ्री कैश फ्लो $42M$39M$27M$-16M$21M

मेरे मेट्रिक्स आपकी व्यक्तिगत वॉचलिस्ट — पूर्ण फंडामेंटल से चयनित पंक्तियाँ

📊

उन मेट्रिक्स को चुनें जो आपके लिए मायने रखते हैं — ऊपर पूर्ण फंडामेंटल में किसी भी पंक्ति के बगल में ➕ पर क्लिक करें।

आपका चयन सहेजा गया है और यह सभी टिकर में आपके साथ रहता है।

संस्थागत मालिक (13F) 173 फाइलर्स · $239.8M कुल · तिथि अनुसार 30 जून 2026

संस्थान जो अपनी तिमाही SEC फॉर्म 13F में इस स्टॉक को होल्ड करने की रिपोर्ट करते हैं। केवल लॉन्ग पोजीशन; एक ही फाइलर अलग-अलग ऑप्शन लेग्स के लिए दो बार दिखाई दे सकता है। बड़े ऑफसेटिंग पुट/कॉल लेग्स आमतौर पर मार्केट-मेकिंग या हेज्ड इन्वेंट्री को दर्शाते हैं, न कि दिशात्मक विश्वास को।

संस्थागत गतिविधि — Q2 2026 बनाम पिछली तिमाही
नई स्थितियाँ बाहर निकली पोजीशन बढ़ाया घटा हुआ शुद्ध शेयर परिवर्तन
28 (+2 पिछली तिमाही की तुलना में) 15 (-2 पिछली तिमाही की तुलना में) 56 (+1 पिछली तिमाही की तुलना में) 47 (+7 पिछली तिमाही की तुलना में) +4.1M

Q1 2026 की तुलना में। SEC फॉर्म 13F फाइलिंग तिमाही के अंत के 45 दिनों के भीतर देय होती है, साथ ही देर से फाइल करने वालों के लिए एक छोटा बफर भी होता है — उस विंडो के भीतर आने वाली तिमाहियों को सबसे हालिया पूरी तरह से रिपोर्ट की गई जोड़ी के पक्ष में छोड़ दिया जाता है।

संस्था मूल्य शेयर % ट्रैक किए गए 13F का प्रकार
ACORN CAPITAL ADVISORS, LLC $33504835 4131299 13.97% शेयर
VANGUARD GROUP INC $21011306 3531312 8.76% शेयर
AMERICAN CENTURY COMPANIES INC $18815168 2319996 7.85% शेयर
RENAISSANCE TECHNOLOGIES LLC $14891687 1836213 6.21% शेयर
VANGUARD CAPITAL MANAGEMENT LLC $14887065 1835643 6.21% शेयर
VANGUARD PORTFOLIO MANAGEMENT LLC $14805608 1825599 6.18% शेयर
DIMENSIONAL FUND ADVISORS LP $11407283 1406570 4.76% शेयर
GEODE CAPITAL MANAGEMENT, LLC $9618136 1185702 4.01% शेयर
O'SHAUGHNESSY ASSET MANAGEMENT, LLC $9113880 1123783 3.80% शेयर
STATE STREET CORP $7722058 952165 3.22% शेयर
KENNEDY CAPITAL MANAGEMENT LLC $7082082 873253 2.95% शेयर
BRIDGEWAY CAPITAL MANAGEMENT, LLC $6420006 791616 2.68% शेयर
RITHOLTZ WEALTH MANAGEMENT $6080862 749798 2.54% शेयर
Connor, Clark & Lunn Investment Management Ltd. $5214292 642946 2.17% शेयर
MILLENNIUM MANAGEMENT LLC $4884166 602240 2.04% शेयर
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP $4318170 532450 1.80% शेयर
GLOBEFLEX CAPITAL L P $3104565 382807 1.29% शेयर
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM $2506850 309106 1.05% शेयर
D. E. Shaw & Co., Inc. $2300377 283647 0.96% शेयर
Russell Investments Group, Ltd. $2207323 272173 0.92% शेयर
VANGUARD FIDUCIARY TRUST CO $2182158 269070 0.91% शेयर
FEDERATED HERMES, INC. $2033712 250766 0.85% शेयर
Empowered Funds, LLC $1786763 220316 0.75% शेयर
PANAGORA ASSET MANAGEMENT INC $1764290 217545 0.74% शेयर
GOLDMAN SACHS GROUP INC $1758256 216801 0.73% शेयर
FMR LLC $1708274 210638 0.71% शेयर
PRUDENTIAL FINANCIAL INC $1600095 197299 0.67% शेयर
STATE OF WISCONSIN INVESTMENT BOARD $1526562 188232 0.64% शेयर
Prospera Financial Services Inc $1287530 158762 0.54% शेयर
Haven Private, LLC $1203913 148448 0.50% शेयर
TWO SIGMA INVESTMENTS, LP $1140161 140587 0.48% शेयर
BlackRock, Inc. $1134784 139924 0.47% शेयर
FIRST TRUST ADVISORS LP $1055970 130206 0.44% शेयर
Bank of New York Mellon Corp $1048964 129342 0.44% शेयर
Round Rock Advisors LLC $1045476 128912 0.44% शेयर
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $1040051 128243 0.43% शेयर
STRS OHIO $686106 84600 0.29% शेयर
CANADA PENSION PLAN INVESTMENT BOARD $596085 73500 0.25% शेयर
Trexquant Investment LP $585729 72223 0.24% शेयर
Vise Technologies, Inc. $584163 72030 0.24% शेयर
SUSQUEHANNA INTERNATIONAL GROUP, LLP $520662 64200 0.22% कॉल ऑप्शन
NOMURA ASSET MANAGEMENT INTERNATIONAL INC. $497000 61255 0.21% शेयर
OpenArc Corporate Advisory, LLC $482472 59491 0.20% शेयर
RHUMBLINE ADVISERS $466397 57510 0.19% शेयर
TWO SIGMA ADVISERS, LP $423045 71100 0.18% शेयर
D'Orazio & Associates, Inc. $394795 48680 0.16% शेयर
Vanguard Global Advisers, LLC $375225 46267 0.16% शेयर
DEUTSCHE BANK AG\ $350287 43192 0.15% शेयर
Man Group plc $336614 41506 0.14% शेयर
WELLINGTON MANAGEMENT GROUP LLP $333240 41090 0.14% शेयर
WINTON GROUP Ltd $328528 40509 0.14% शेयर
XTX Topco Ltd $326801 40296 0.14% शेयर
State of Wyoming $323046 39833 0.13% शेयर
WELLS FARGO & COMPANY/MN $304977 37605 0.13% शेयर
EntryPoint Capital, LLC $303200 37386 0.13% शेयर
Baron Wealth Management LLC $294977 36372 0.12% शेयर
Creative Planning $289827 35737 0.12% शेयर
LPL Financial LLC $280095 34537 0.12% शेयर
Universal- Beteiligungs- und Servicegesellschaft mbH $279673 34485 0.12% शेयर
BANK OF AMERICA CORP /DE/ $257468 31747 0.11% शेयर
Kathmere Capital Management, LLC $252805 31172 0.11% शेयर
FRANKLIN RESOURCES INC $242165 29860 0.10% शेयर
ENVESTNET ASSET MANAGEMENT INC $236731 29190 0.10% शेयर
Y-Intercept (Hong Kong) Ltd $212660 26222 0.09% शेयर
MARTINGALE ASSET MANAGEMENT L P $205703 25364 0.09% शेयर
Metis Global Partners, LLC $204891 25264 0.09% शेयर
MetLife Investment Management, LLC $201720 24873 0.08% शेयर
SUSQUEHANNA INTERNATIONAL GROUP, LLP $195451 24100 0.08% पुट ऑप्शन
C2C Wealth Management, LLC $191558 23620 0.08% शेयर
Nuveen, LLC $187982 23179 0.08% शेयर
PRELUDE CAPITAL MANAGEMENT, LLC $174754 21548 0.07% शेयर
One Wealth Advisors, LLC $170951 21079 0.07% शेयर
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. $165306 20383 0.07% शेयर
CITIGROUP INC $154990 19111 0.06% शेयर
BAILARD, INC. $146791 18100 0.06% शेयर
Invesco Ltd. $142493 17570 0.06% शेयर
JANE STREET GROUP, LLC $141925 17500 0.06% कॉल ऑप्शन
Spark Investment Management LLC $137870 17000 0.06% शेयर
MORGAN STANLEY $137416 16944 0.06% शेयर
ALLIANCEBERNSTEIN L.P. $136490 21360 0.06% शेयर
Brandywine Global Investment Management, LLC $129710 21800 0.05% शेयर
Police & Firemen's Retirement System of New Jersey $127481 15719 0.05% शेयर
SUSQUEHANNA INTERNATIONAL GROUP, LLP $125510 15476 0.05% शेयर
Lido Advisors, LLC $122015 15045 0.05% शेयर
Mariner, LLC $120593 14869 0.05% शेयर
Caprock Group, LLC $112421 13862 0.05% शेयर
PERKINS CAPITAL MANAGEMENT INC $108674 13400 0.05% शेयर
TOCQUEVILLE ASSET MANAGEMENT L.P. $107960 13312 0.05% शेयर
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC $105624 13203 0.04% शेयर
UBS Group AG $99923 12321 0.04% शेयर
MANUFACTURERS LIFE INSURANCE COMPANY, THE $97774 12056 0.04% शेयर
CWM, LLC $97531 15263 0.04% शेयर
R Squared Ltd $97247 11991 0.04% शेयर
Abel Hall, LLC $93427 11520 0.04% शेयर
IEQ CAPITAL, LLC $86542 10671 0.04% शेयर
Williams & Novak, LLC $85066 10489 0.04% शेयर
Vanguard Personalized Indexing Management, LLC $84409 10408 0.04% शेयर
Ethic Inc. $83290 10270 0.03% शेयर
AQR CAPITAL MANAGEMENT LLC $83136 10251 0.03% शेयर
INTECH INVESTMENT MANAGEMENT LLC $82803 10210 0.03% शेयर

कंपनी के अंदरूनी सूत्र 24 इनसाइडर्स · 10 अधिकारी · 12 निदेशक

अंदरूनी भूमिका अंतिम गतिविधि शेयरों का स्वामित्व खरीद 12m बिक्री 12m नेट 12m
Alan H Auerbach President and CEO 6 जुलाई 2026 S 7261671 0 1 $-363919
Maximo F Nougues Chief Financial Officer 6 जुलाई 2026 S 230637 0 1 $-77528
Douglas M Hunt The Reporting Person is the Senior Vice President of Regulatory Affairs of the Issuer. 6 जुलाई 2026 S 196841 0 1 $-69880
Alvin F Wong Chief Scientific Officer 17 जून 2021 A 0 0 $0
Richard Paul Bryce Title of Reporting Person: Chief Medical and Scientific Officer 5 अप्रैल 2021 S 121662 0 0 $0
Jeffrey Jerome Ludwig Chief Commercial Officer 17 फ़रवरी 2021 A 36069 0 0 $0
Steven Lo Chief Commercial Officer 22 जुलाई 2019 S 19557 0 0 $0
Charles R Eyler Title of Reporting Person: Senior Vice President, Finance and Administration and Treasurer 4 फ़रवरी 2019 S 31957 0 0 $0
Robert Charnas The Reporting Person is the Senior Vice President of Regulatory Affairs and Project Management of the Issuer. 16 फ़रवरी 2017 A 26453 0 0 $0
Richard Benton Phillips The Reporting Person is the Interim Head of Regulatory Affairs, Quality Assurance and Pharmacovigilance of the Issuer. 15 अप्रैल 2016 A 0 0 $0
Brian M Stuglik निदेशक 12 जून 2026 S 113858 0 1 $-58320
Allison Dorval निदेशक 12 जून 2026 S 90780 0 1 $-83592
Adrian Senderowicz निदेशक 12 जून 2026 S 27000 0 1 $-194400
Troy Edward Wilson निदेशक 12 जून 2026 S 59750 0 1 $-77760
Jay M Moyes निदेशक 12 जून 2026 S 58322 0 1 $-158840
Alessandra Cesano निदेशक 11 जून 2026 A 68850 0 0 $0
MILLER MICHAEL PATRICK निदेशक 11 जून 2026 A 81000 0 0 $0
Ann Calby Miller निदेशक 15 जून 2021 A 40732 0 0 $0
Hugh O'Dowd निदेशक 9 जून 2020 A 25748 0 0 $0
Frank Zavrl निदेशक 9 जून 2020 A 50993 0 0 $0
Thomas Malley निदेशक 15 दिसमबर 2014 A 156551 0 0 $0
Faraaz Siddiqi 4 अक्टूबर 2011 D 0 0 0 $0
Kapil Munjal 4 अक्टूबर 2011 D 0 0 0 $0
Robert Andrew Johnson 4 अक्टूबर 2011 D 0 0 0 $0

SEC फॉर्म 3/4/5 फाइलिंग से अंदरूनी सूत्र; नेट = केवल ओपन-मार्केट P/S

कार्यकर्ता और 5%+ मालिक 7 होल्डिंग्स

जिन निवेशकों ने SEC शेड्यूल 13D दाखिल किया है — जारीकर्ता को प्रभावित करने के इरादे से 5% से अधिक लाभकारी स्वामित्व (कार्यकर्ता दांव, बोर्ड अभियान, M&A)। प्रत्येक पंक्ति उस फाइलर की स्थिति की सबसे हालिया ज्ञात स्थिति दिखाती है।

फाइलर दाखिल किया दांव स्थिति उद्देश्य फाइलिंग
Alan H. Auerbach ×6 फाइलिंग 13 दिसमबर 2022 प्रारंभिक फाइलिंग SEC
Kapil Munjal 2) 4 अक्टूबर 2011 प्रारंभिक फाइलिंग SEC
Faraaz Siddiqi 2) 4 अक्टूबर 2011 प्रारंभिक फाइलिंग SEC
Robert Johnson 2) 4 अक्टूबर 2011 प्रारंभिक फाइलिंग SEC
Robert Johnson 21 नवमबर 2007 प्रारंभिक फाइलिंग SEC
अघोषित रिपोर्टिंग व्यक्ति 19 नवमबर 2007 प्रारंभिक फाइलिंग SEC
Faraaz Siddiqi 19 नवमबर 2007 प्रारंभिक फाइलिंग SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

ईटीएफ स्वामित्व 36 ETFs द्वारा धारित

वजन केवल प्रत्यक्ष इक्विटी होल्डिंग्स (N-PORT) को दर्शाता है; लीवरेज्ड या डेरिवेटिव-आधारित फंड में अतिरिक्त स्वैप एक्सपोजर हो सकता है जो नहीं दिखाया गया है।

फंड भार इकाइयाँ तिथि अनुसार स्रोत
ROSC · Lattice Strategies Trust 0.72% 52608 NS 30 अप्रैल 2026 N-PORT
DWAS · Invesco Exchange-Traded Fund Trust … 0.46% 233908 SH 8 अगस्त 2026 दैनिक
IWC · iShares Trust 0.08% 150797 SH 8 अगस्त 2026 दैनिक
VFQY · VANGUARD WELLINGTON FUND 0.06% 34260 SH 8 अगस्त 2026 दैनिक
AVUV · AMERICAN CENTURY ETF TRUST 0.05% 1924360 NS 31 मई 2026 N-PORT
GSSC · Goldman Sachs ETF Trust 0.04% 55680 NS 31 मई 2026 N-PORT
IBBQ · Invesco Exchange-Traded Fund Trust … 0.03% 2746 SH 8 अगस्त 2026 दैनिक
AVSC · AMERICAN CENTURY ETF TRUST 0.02% 95559 NS 31 मई 2026 N-PORT
VTWV · VANGUARD SCOTTSDALE FUNDS 0.02% 32358 SH 8 अगस्त 2026 दैनिक
IWN · iShares Trust 0.02% 356623 SH 8 अगस्त 2026 दैनिक
BIB · ProShares Trust 0.02% 1879 NS 31 मई 2026 N-PORT
PRFZ · Invesco Exchange-Traded Fund Trust 0.02% 55064 SH 8 अगस्त 2026 दैनिक
IWM · iShares Trust 0.01% 1153241 SH 8 अगस्त 2026 दैनिक
RSSL · Global X Funds 0.01% 19123 NS 30 अप्रैल 2026 N-PORT
VFMO · VANGUARD WELLINGTON FUND 0.01% 16014 SH 8 अगस्त 2026 दैनिक
VTWO · VANGUARD SCOTTSDALE FUNDS 0.01% 254380 SH 8 अगस्त 2026 दैनिक
DFAS · Dimensional ETF Trust 0.01% 166672 NS 30 अप्रैल 2026 N-PORT
DFAT · Dimensional ETF Trust 0.01% 156761 NS 30 अप्रैल 2026 N-PORT
DFSV · Dimensional ETF Trust 0.01% 82003 NS 30 अप्रैल 2026 N-PORT
ITWO · ProShares Trust 0.01% 2027 NS 31 मई 2026 N-PORT
DXUV · Dimensional ETF Trust 0.01% 3611 NS 30 अप्रैल 2026 N-PORT
EBI · RBB Fund Trust 0.01% 5394 NS 31 मई 2026 N-PORT
UWM · ProShares Trust 0.00% 1585 NS 31 मई 2026 N-PORT
IWO · iShares Trust 0.00% 65370 SH 8 अगस्त 2026 दैनिक
URTY · ProShares Trust 0.00% 1603 NS 31 मई 2026 N-PORT
MSSM · MORGAN STANLEY PATHWAY FUNDS 0.00% 2071 NS 31 मई 2026 N-PORT
AVUS · AMERICAN CENTURY ETF TRUST 0.00% 34919 NS 31 मई 2026 N-PORT
DCOR · Dimensional ETF Trust 0.00% 6348 NS 30 अप्रैल 2026 N-PORT
HDG · ProShares Trust 0.00% 40 NS 31 मई 2026 N-PORT
DFAU · Dimensional ETF Trust 0.00% 9704 NS 30 अप्रैल 2026 N-PORT
DFUS · Dimensional ETF Trust 0.00% 15090 NS 30 अप्रैल 2026 N-PORT
DFAC · Dimensional ETF Trust 0.00% 12376 NS 30 अप्रैल 2026 N-PORT
VXF · VANGUARD INDEX FUNDS 0.00% 446899 SH 8 अगस्त 2026 दैनिक
VTI · VANGUARD INDEX FUNDS 0.00% 1343121 SH 8 अगस्त 2026 दैनिक
VTWG · VANGUARD SCOTTSDALE FUNDS 0.00% 7680 SH 8 अगस्त 2026 दैनिक
VTHR · VANGUARD SCOTTSDALE FUNDS 0.00% 2979 SH 8 अगस्त 2026 दैनिक